Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS CHESHIRE AND MERSEYSIDE INTEGRATED CARE BOARD
QYG
No1 Lakeside, 920 Centre Park
Warrington
WA11QY
UK
Contact person: Richard Hampson
E-mail: richard.hampson@cheshireandmerseyside.nhs.uk
NUTS: UKD61
Internet address(es)
Main address: www.cheshireandmerseyside.nhs.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Community Pharmacy Trans Health Medicines Stockholding - Sefton
Reference number: 25-26-QYG-01T-TRANS
II.1.2) Main CPV code
85100000
II.1.3) Type of contract
Services
II.1.4) Short description
The Pharmacy will maintain an agreed stock of medicines used in the treatment of gender dysphoria and ensure timely access to medicines used in the treatment of gender dysphoria. Also to support the health and wellbeing of transgender people, ensuring they have access to high quality information and advice in a safe and inclusive environment.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
.01
GBP
II.2) Description
II.2.2) Additional CPV code(s)
85100000
II.2.3) Place of performance
NUTS code:
UKD73
Main site or place of performance:
Multiple Pharmacies across the South Sefton area.
II.2.4) Description of the procurement
NHS Cheshire and Merseyside ICB has awarded a one year contract via Direct Award A to selected Sefton Pharmacies across Cheshire and Merseyside. The contract commenced on 1st April 2025 and will expire on 31st March 2026. The contract value is 0 and is activity based contract. Funding is based on delivery of the activity outlined within the service specification.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provision of the Public Contracts Regulations 2015 do not apply to this award.
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
Section V: Award of contract
Contract No: 25-26-QYG-01T-FKT64-CON-V1
Title: Community Pharmacy Trans Health Medicines Stockholding - Sefton
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
19/11/2024
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
ASDA Stores Limited
FKT64
ASDA, 81 Strand Road, Bootle
Liverpool
L20 4BB
UK
NUTS: UKD73
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: .01
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
On the 19th of November 2024 the Finance, Investment, Resources Committee approved this decision.
One Committee member have a standing
declaration of interest. The decision to award was
made in line with the Conflict of Interest policy.
VI.4) Procedures for review
VI.4.1) Review body
NHS Cheshire and Merseyside ICB
No 1 Lakeside, 920 Centre Park
Warrington
WA11QY
UK
Internet address(es)
URL: www.cheshireandmerseyside.nhs.uk
VI.5) Date of dispatch of this notice
30/04/2025